The Home moved final week to cap the price of insulin, and Democrats assume they’ve discovered a winner to save lots of seats in November. What ghoul might oppose cheaper insulin? Alas the invoice misdiagnoses the issue and is a pretext for extra political management of drug costs, which gained’t serve struggling Individuals.
The Reasonably priced Insulin Now Act caps cost-sharing for insulin at $35 a month for diabetics with non-public insurance coverage or on Medicare Half D. The invoice’s Democratic sponsors name it “a crucial drug pricing reform” to cope with “the skyrocketing price of insulin.” The invoice handed 232-193.
